EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA-LIPIDS IN FAMILIAL HYPERCHOLESTEROLEMIA

被引：0
|
作者：
MOL, MJTM
LEUVEN, JAG
ERKELENS, DW
SCHOUTEN, JA
STALENHOEF, AFH
机构：
[1] ST RADBOUD UNIV HOSP, DEPT INTERNAL MED, POB 9101, 6500 HB NIJMEGEN, NETHERLANDS
[2] STATE UNIV UTRECHT HOSP, DEPT INTERNAL MED, 3511 GV UTRECHT, NETHERLANDS
[3] STATE UNIV LEIDEN HOSP, DEPT INTERNAL MED, 2333 AA LEIDEN, NETHERLANDS
[4] TNO, GAUBIUS INST CARDIOVASC RES, UTRECHT, NETHERLANDS
[5] FREE UNIV AMSTERDAM HOSP, AMSTERDAM, NETHERLANDS
来源：
LANCET | 1986年 / 2卷 / 8513期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：936 / 939
页数：4
相关论文
共 50 条
  • [1] MK-733 - POTENT INHIBITOR OF CHOLESTEROL-SYNTHESIS IN FAMILIAL HYPERCHOLESTEROLEMIA
    STALENHOEF, AF
    LEUVEN, JAG
    SCHOUTEN, JA
    ERKELENS, DW
    ARTERIOSCLEROSIS, 1987, 7 (05): : A516 - A516
  • [2] EFFECTS OF MK-733 ON PLASMA-LIPID AND LIPOPROTEIN LEVELS IN SUBJECTS WITH HYPERCHOLESTEROLEMIA
    SIMONS, LA
    NESTEL, PJ
    CALVERT, GD
    JENNINGS, GL
    MEDICAL JOURNAL OF AUSTRALIA, 1987, 147 (02) : 65 - 68
  • [3] SYNVINOLIN (MK-733) THERAPY FOR TYPE-II HYPERLIPOPROTEINEMIA
    DARIOLI, R
    BOVET, P
    PETRILLO, A
    BRUNNER, HR
    THERAPIE, 1988, 43 (02): : 160 - 160
  • [4] SIMVASTATIN (MK-733) - A POTENT CHOLESTEROL-SYNTHESIS INHIBITOR IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MOL, MJTM
    ERKELENS, DW
    LEUVEN, JAG
    SCHOUTEN, JA
    STALENHOEF, AFH
    ATHEROSCLEROSIS, 1988, 69 (2-3) : 131 - 137
  • [5] EFFECTIVENESS AND TOLERANCE OF SYNVINOLIN (MK-733) IN TREATMENT OF TYPE-II HYPERLIPOPROTEINEMIA
    DARIOLI, R
    BOVET, P
    PETRILLO, A
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, : 16 - 16
  • [6] BEZAFIBRATE AND SIMVASTATIN (MK-733) IN THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA
    SMITH, DHG
    NEUTEL, JM
    JANKELOW, D
    MYBURGH, DP
    SOUTH AFRICAN MEDICAL JOURNAL, 1990, 77 (10): : 500 - 503
  • [7] CHOLESTEROL REDUCTION IN FAMILIAL AND POLYGENIC HYPERCHOLESTEROLEMIA BY THE NEW HMG COA REDUCTASE INHIBITOR MK-733
    MOLGAARD, J
    VONSCHENCK, H
    OLSSON, AG
    CIRCULATION, 1987, 76 (04) : 93 - 93
  • [8] LOW-DOSE EFFECT OF SIMVASTATIN (MK-733) ON SERUM-LIPIDS, LIPOPROTEINS, AND APOLIPOPROTEINS IN PATIENTS WITH HYPERCHOLESTEROLEMIA
    SAKU, K
    SASAKI, J
    ARAKAWA, K
    CLINICAL THERAPEUTICS, 1989, 11 (02) : 247 - 257
  • [9] BEZAFIBRATE AND CLOFIBRATE - EFFECTS ON PLASMA-LIPIDS, LIPOPROTEINS AND APOPROTEINS COMPARED IN FAMILIAL HYPERCHOLESTEROLEMIA
    MARTINI, S
    VALERIO, G
    FELLIN, R
    BAGGIO, G
    GASPAROTTO, A
    BAIOCCHI, MR
    BALDO, G
    CREPALDI, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 31 (03): : 354 - 361
  • [10] EFFECTS OF SIMVASTATIN (MK-733) ON BRANCHED PATHWAY OF MEVALONATE
    NAGATA, Y
    HIDAKA, Y
    ISHIDA, F
    KAMEI, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 54 (03): : 315 - 324
12345